Carolina Padovani
Carolina Padovani has been the Scientific Affairs & Communication Manager at Royal Canin Brazil since January 2016. Her backgroud is in veterinary medicine and she has a master's degree in pet nutrition. She started her career at Royal Canin with a regulatory affairs implementation area in 2010. Since then she has developed some projects and get the opportunity to navigate in different areas such as R&D, MKT, Corporate Affairs, Public Affairs. In her current position, she manages the areas of technical knowledge and relationship with KOL and universities.
Sergio Zimerman
Veronika Oudova
Veronika is a co-founder and Chief Executive Officer of S-Biomedic.
Veronika completed a master study in International Trade in Prague and a master in International Management within the program CEMS located in Prague, Vienna and Rotterdam. After her studies she has worked as project manager and marketing consultant at Cord Blood Bank Czech Republic. There she also co-founded a spin-off company StemCellPro.
Before joining the project S-Biomedic Veronika has worked as account manager, business analyst and quality manager in the market research industry.
Trevor Steyn
Trevor Steyn is the CEO and founder of Esse Skincare. As an organic chemist his research has taken a broader approach to optimising skin health in the long term. Esse launched its first live probiotic product in February 2015 and has subsequently pioneered several new technologies in modulating the skin microbiome.
Thomas Hitchcock
Thomas Hitchcock is the founder and CEO of Xycrobe Therapeutics. An entrepreneur in the biotech space, Thomas has been instrumental in bringing several medical technologies successfully to the dermatological and aesthetics markets. Thomas holds a doctorate in molecular genetics from Clemson University where he did his research on DNA damage and repair. He has completed postdoctoral training at both Duke University in the Biomedical Engineering Department and Yale University in the Program in Vascular Biology and Therapeutics where he was involved in ground-breaking research and development of in vitro engineered human cardiovascular and pulmonary tissues. He has also performed research at Weill Cornell Medical College in the Department of Oncology and Hematology where he studied multiple myeloma genetics. Prior to Xycrobe, he was the Director of Medical Affairs for Ulthera, Inc., and part of the team that brought their platform technology to acquisition in July 2014 by Merz pharmaceuticals. Thomas also currently travels the country lecturing to medical professionals about skincare and aesthetics in dermatology.